Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Ipca Laboratories Limited

Market Cap 402B 4.23B 3.65B 3.36B 3.15B 5.9B 5.99B 39.71B 15.48B 195B 15.86B 15.52B 677B P/E Ratio 2026
35.6x
P/E Ratio 2027 * 28.8x
Enterprise Value 397B 4.17B 3.6B 3.32B 3.11B 5.83B 5.92B 39.21B 15.29B 193B 15.66B 15.33B 668B EV / Sales 2026
4.24x
EV / Sales 2027 * 3.57x
Free-Float
54.92%
Yield 2026
0.37%
Yield 2027 * 0.37%
1 day-1.90%
1 week-1.92%
Current month+3.84%
1 month+3.13%
3 months+3.20%
6 months+7.55%
Current year+11.57%
1 week 1,568.6
Extreme 1568.6
1,670
1 month 1,470
Extreme 1470
1,678.3
Current year 1,391.8
Extreme 1391.8
1,678.3
1 year 1,251.6
Extreme 1251.6
1,678.3
3 years 691.2
Extreme 691.2
1,755.9
5 years 669.8
Extreme 669.8
1,755.9
10 years 200
Extreme 200
1,755.9
Manager TitleAgeSince
Chief Executive Officer 53 01/04/2023
Chief Executive Officer 70 01/04/2023
Chief Tech/Sci/R&D Officer 52 16/10/2023
Director TitleAgeSince
Chairman 79 05/07/2012
Director/Board Member 53 11/11/2008
Director/Board Member 70 01/08/1994
Date Insider Type Main position Quantity % Market Cap.
19/12/24Sell 4,000,000 1.5766%
Change 5-day change 1-year change 3-year change Capi.($)
-1.90%-1.92%+13.93%+117.46% 4.28B
-2.21%+0.55%+40.10%+155.47% 1,035B
+0.87%+3.42%+53.67%+50.56% 574B
+1.00%-0.22%+17.84%+64.63% 397B
+0.58%+0.77%+21.19%+15.95% 324B
-0.85%-2.86%+22.05%+13.80% 281B
+0.44%+3.48%+24.48%+34.39% 278B
+1.66%+5.61%-44.67%-47.49% 193B
-0.05%+1.26%+19.07%+62.85% 191B
-0.27%-2.77%+12.07%+61.29% 156B
Average -0.07%+1.51%+17.97%+52.89% 343.42B
Weighted average by Cap. -0.33%+2.39%+28.02%+71.97%

Financials

2026 2027 *
Net sales 96.62B 1.02B 878M 809M 757M 1.42B 1.44B 9.55B 3.72B 47.03B 3.81B 3.73B 163B 108B 1.13B 979M 902M 844M 1.58B 1.61B 10.65B 4.15B 52.43B 4.25B 4.16B 182B
Net income 11.21B 118M 102M 93.85M 87.84M 165M 167M 1.11B 432M 5.46B 443M 433M 18.89B 14.04B 148M 128M 118M 110M 206M 209M 1.39B 541M 6.83B 554M 542M 23.66B
Net Debt -5.02B -52.78M -45.59M -42.01M -39.32M -73.69M -74.83M -496M -193M -2.44B -198M -194M -8.46B -17.17B -181M -156M -144M -135M -252M -256M -1.7B -662M -8.36B -678M -663M -28.94B
Logo Ipca Laboratories Limited
Ipca Laboratories Limited is an India-based integrated pharmaceutical company. The Company is engaged in manufacturing and marketing over 350 formulations and approximately 80 active pharmaceutical ingredients (APIs) covering various therapeutic segments. It offers APIs, such as Atenolol, Chloroquine Phosphate, Chlorthalidone, Furosemide, Hydroxychloroquine sulfate, Losartan, Metoprolol Succinate, Metoprolol Tartrate, Pyrantel Salts and Propranolol. The Company offers brands, such as Zerodol, Lariago, HCQS, Perinorm, Rapither AB, Tenoric, Lumerax, Etova, Fexova, Malirid, Allsuth, Alwiz, AZR 50mg, Bacilon, Cinkona, Clarbact, Glyree MV, Halotop, Luliz, Ozepam, Pacimol, Pari, Xtor-F, Zabpro, Zilast, Ramcor, Sove, Venpower and Folitrax. The Company’s products are sold in over 100 countries across the globe. The Company has 18 manufacturing units in India manufacturing APIs and formulations. Its subsidiaries include Ipca Pharmaceuticals, Inc. and Ipca Pharma Nigeria Ltd.
Employees
16,778
Date Price Change Volume
12/06/26 1,583.00 -1.90% 131,987
11/06/26 1,613.60 -1.02% 86,082
10/06/26 1,630.20 -0.23% 172,179
09/06/26 1,634.00 -0.93% 116,776
08/06/26 1,649.40 +0.46% 924,718
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
1,583.00INR
Average target price
1,719.61INR
Spread / Average Target
+8.63%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IPCALAB Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!